Recent Finacing
Recent Raise
Immune Targeting Systems is a London-based biotech developing synthetic vaccine FP-01 against diverse seasonal and pandemic influenza strains, conducting phase I and II clinical trials assessing safety and efficacy.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors